Article
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2017
Asghar Uzma S, Barr Alexis R, Cutts Ros, Beaney Matthew, Babina Irina, Sampath Deepak, Giltnane Jennifer, Lacap Jennifer Arca, Crocker Lisa, Young Amy, Pearson Alex, Herrera-Abreu Maria Teresa, Bakal Chris, Turner Nicholas C
Abstract excerpt
Purpose: Triple-negative breast cancer (TNBC) is a heterogeneous subgroup of breast cancer that is associated with a poor prognosis. We evaluated the activity of CDK4/6 inhibitors across the TNBC subtypes and investigated mechanisms of sensitivity.Experimental Design: A panel of cell lines representative of TNBC was tested for in vitro and in vivo sensitivity to CDK4/6 inhibition. A fluorescent CDK2 activity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
